KIT and platelet-derived growth factor receptor gene expression in laryngeal small cell carcinoma

Journal of Laryngology and Otology

Volumn 124, Issue 12, 2010, Pages 1340-1343

  Kanazawa, T ^a   Nokubi, M ^a   Takizawa, K ^a   Matsuzawa, S ^a   Shinnabe, A ^a   Mineta, H ^b   Iino, Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biological Therapy; Head And Neck Neoplasms; KIT; Larynx; Neuroendocrine Tumors; Platelet Derived Growth Factor Receptor Alpha; Small Cell Carcinoma

Indexed keywords

CISPLATIN; ETOPOSIDE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

AGED; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIT GENE; LARYNGEAL BIOPSY; LARYNGOSCOPY; LARYNX CARCINOMA; LUNG METASTASIS; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; RECEPTOR GENE; SMALL CELL CARCINOMA;

AGED; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; FATAL OUTCOME; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MALE; MOLECULAR TARGETED THERAPY; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 78649956773     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215110001465     Document Type: Article

References (19)

1. Wenig BM, Hyams VJ, Heffner DK. Moderately differentiated neuroendocrine carcinoma of the larynx. A clinicopathologic study of 54 cases. Cancer 1988;62:2658-76
2. Ferlito A, Barnes L, Rinaldo A, Gnepp DR, Milroy CM. A review of neuroendocrine neoplasms of the larynx: Update on diagnosis and treatment. J Laryngol Otol 1998;112: 827-34
3. Renner G. Small cell carcinoma of the head and neck: A review. Semin Oncol 2007;34:3-14
4. Gnepp DR. Small cell neuroendocrine carcinoma of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec 1991;53:210-19
5. Baugh RF, Wolf GT, McClatchey KD. Small cell carcinoma of the head and neck. Head Neck Surg 1986;8:343-54
6. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659-72
7. Moriguchi H, Kim TY, Sato C. Gefitinib for refractory advanced non-small-cell lung cancer. Lancet 2006;367: 299-300
8. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB et al. Radiotherapy plus cetuximab for squamous- cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78
9. Yamamoto R, Hosokawa S, Yamatodani T, Morita S, Okamura J, Mineta H. Eight cases of neuroendocrine carcinoma of the head and neck [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 2008;111:517-22
10. Aguilar EA 3rd, Robbins KT, Stephens J, Dimery IW, Batsakis JG. Primary oat cell carcinoma of the larynx. Am J Clin Oncol 1987;10:26-32
11. Ferlito A, Pesavento G, Recher G, Caruso G, Dal Fior S, Montaguti A et al. Long-term survival in response to combined chemotherapy and radiotherapy in laryngeal small cell carcinoma. Auris Nasus Larynx 1986;13:113-23
12. Galanis E, Frytak S, Lloyd RV. Extrapulmonary small cell carcinoma. Cancer 1997;79:1729-36
13. Cassier PA, Dufresne A, Arifi S, El Sayadi H, Labidi I, Ray-Coquard I et al. Imatinib mesilate for the treatment of gastrointestinal stromal tumour. Expert Opin Pharmacother 2008;9:1211-22
14. Fletcher JA. Role of KITand platelet-derived growth factor receptors as oncoproteins. Semin Oncol 2004;31:4-11
15. Terada T. Primary extragastrointestinal stromal tumor of the transverse mesocolon without c-kit mutations but with PDGFRA mutations. Med Oncol 2009;26:233-7
16. Terada T. Primary small cell carcinoma of the mediastinum: A case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2009;26:247-50
17. Benjamin RS, Debiec-Rychter M, Le Cesne A, Sleijfer S, Demetri GD, Joensuu H et al. Gastrointestinal stromal tumors II: Medical oncology and tumor response assessment. Semin Oncol 2009;36:302-11
18. Boldrini L, Ursino S, Gisfredi S, Faviana P, Donati V, Camacci T et al. Expression and mutational status of c-kit in small-cell lung cancer: Prognostic relevance. Clin Cancer Res 2004;10:4101-8
19. Sihto H, Sarlomo-Rikala M, Tynninen O, Tanner M, Andersson LC, Franssila K et al. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors. J Clin Oncol 2005;23:49-57